No abstract available
Keywords:
AHA Scientific Statements; atrial fibrillation; cardio-renal physiology/pathophysiology; cardiovascular surgery: transplantation, ventricular assistance, cardiomyopathy; epidemiology; full revision; health policy and outcome research; other atrial fibrillation.
Publication types
-
Practice Guideline
-
Review
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use
-
Anticoagulants / therapeutic use
-
Arrhythmias, Cardiac / physiopathology
-
Atrial Fibrillation / classification
-
Atrial Fibrillation / physiopathology
-
Atrial Fibrillation / therapy*
-
Autonomic Nervous System / physiopathology
-
C-Reactive Protein / analysis
-
Cardiac Output, Low / physiopathology
-
Catheter Ablation
-
Comorbidity
-
Defibrillators, Implantable
-
Echocardiography, Transesophageal
-
Electric Countershock
-
Electrocardiography
-
Fibrinolytic Agents / therapeutic use
-
Heart Atria / abnormalities
-
Heart Atria / physiopathology
-
Heart Atria / surgery
-
Heart Conduction System / physiopathology
-
Humans
-
Inflammation / physiopathology
-
Natriuretic Peptide, Brain / blood
-
Oxidative Stress / physiology
-
Pacemaker, Artificial
-
Platelet Aggregation Inhibitors / therapeutic use
-
Renin-Angiotensin System / physiology
-
Risk Assessment
-
Risk Factors
-
Septal Occluder Device
-
Stroke / etiology
-
Stroke / prevention & control
-
Thromboembolism / physiopathology
-
Thromboembolism / prevention & control
-
Ventricular Remodeling / physiology
Substances
-
Anti-Arrhythmia Agents
-
Anticoagulants
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Natriuretic Peptide, Brain
-
C-Reactive Protein